Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Rigel Pharmaceuticals Inc. (RIGL)

1.94   -0.05 (-2.51%) 08-20 15:17
Open: 1.99 Pre. Close: 1.99
High: 2.005 Low: 1.92
Volume: 368,440 Market Cap: 324M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.043 - 2.053 2.053 - 2.062
Low: 1.897 - 1.908 1.908 - 1.918
Close: 1.971 - 1.99 1.99 - 2.007

Technical analysis

as of: 2019-08-20 3:01:20 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.67     One year: 2.97
Support: Support1: 1.87    Support2: 1.56
Resistance: Resistance1: 2.28    Resistance2: 2.54
Pivot: 2.10
Moving Average: MA(5): 1.95     MA(20): 2.15
MA(100): 2.28     MA(250): 2.52
MACD: MACD(12,26): -0.11     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 16.99     %D(3): 12.36
RSI: RSI(14): 33.18
52-week: High: 3.65  Low: 1.87  Change(%): -27.4
Average Vol(K): 3-Month: 115936  10-Days: 113324

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
RIGL has closed above bottom band by 20.2%. Bollinger Bands are 46.5% wider than normal. The large width of the bands suggest high volatility as compared to RIGL's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Wed, 07 Aug 2019 03:11:12 Z
Rigel Pharmaceuticals Inc (RIGL) Q2 2019 Earnings Call Transcript

Wed, 07 Aug 2019 00:13:08 Z
Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates

Fri, 02 Aug 2019 15:09:18 Z
Is a Beat in the Cards for Regeneron (REGN) Q2 Earnings?

Fri, 02 Aug 2019 15:08:12 Z
What's in the Cards for Bausch Health (BHC) in Q2 Earnings?

Mon, 01 Jul 2019 13:41:40 Z
Rigel Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 167.19
Shares Float (M) 166.71
% Held by Insiders 0.25
% Held by Institutions 97.74
Shares Short (K) 14770
Shares Short P. Month (K)

Stock Financials

EPS -0.385
EPS Est. Current Year -0.600
EPS Est. Next Year -0.430
EPS Est. Next Quarter -0.150
Forward EPS -0.470
Book Value (p.s.) 0.570
PEG Ratio -0.10
Profit Margin -111.48
Operating Margin -116.09
Return on Assets (ttm) -30.5
Return on Equity (ttm) -72.7
Qtrly Rev. Growth
Gross Profit (p.s.) -0.016
Sales Per Share
EBITDA (p.s.) -0.393
Qtrly Earnings Growth
Operating Cash Flow (M) -36.00
Levered Free Cash Flow (M) -41.46

Stock Valuations

P/E -5.05
P/E Growth Ratio -0.02
P/BV 3.41
P/S 956425216.00
P/CF -9.03

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.